Logo
x

Search

Subscribe Now

Multiple sclerosis

Enhancing Multiple Sclerosis Research: Dr. Kari Wong and Dr. Emma Tallantyre in Conversation with PharmaShots

Enhancing Multiple Sclerosis Research: Dr. Kari Wong and Dr. Emma Tallantyre in Conversation with PharmaShots

  • June 17, 2024
PharmaShots Interview: Biogen’s Monica Mann Shares Insights on the New Real-World Data on Tysabri & Vumerity for the Treatment of Multiple Sclerosis

PharmaShots Interview: Biogen’s Monica Mann Shares Insights on the New Real-World Data on Tysabri & Vumerity for the Treatment of...

  • May 17, 2022
Sanofi Presents Results of Tolebrutinib in a P-IIb LTS for Relapsing Forms of Multiple Sclerosis at ECTRIMS 2021

Sanofi Presents Results of Tolebrutinib in a P-IIb LTS for Relapsing Forms of Multiple Sclerosis at ECTRIMS 2021

  • October 13, 2021
Roche Collaborates with Temedica to Launch Brisa App for the Treatment of Multiple Sclerosis

Roche Collaborates with Temedica to Launch Brisa App for the Treatment of Multiple Sclerosis

  • September 15, 2021
Wise and NYU Langone Health Publish the Results of Personal Zen App for Multiple Sclerosis in Frontiers in Neurology

Wise and NYU Langone Health Publish the Results of Personal Zen App for Multiple Sclerosis in Frontiers in Neurology

  • August 13, 2021
Biogen Signs a License Agreement with Innocare for Orelabrutinib to Treat Multiple Sclerosis

Biogen Signs a License Agreement with Innocare for Orelabrutinib to Treat Multiple Sclerosis

  • July 13, 2021
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.